STIL and hepatocellular carcinoma: First, the ceRNA regulation axis of STIL was only predicted using online databases, thereby needing to be validated in vitro experiments; second, the potential molecular mechanisms of STIL and tumor-immune cell interactions in HCC should be confirmed in vivo experiments.